학술논문
Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real-world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial
Document Type
Article
Author
Tada, T.; Nakamura, S.; Kumada, T.; Hiraoka, A.; Tada, F.; Hirooka, M.; Koizumi, Y.; Hiasa, Y.; Kariyama, K.; Nouso, K.; Tani, J.; Morishita, A.; Atsukawa, M.; Itokawa, N.; Okubo, T.; Arai, T.; Takaguchi, K.; Tsutsui, A.; Nagano, T.; Itobayashi, E.; Fukunishi, S.; Nishimura, T.; Enomoto, H.; Nishikawa, H.; Tsuji, K.; Ishikawa, T.; Imai, M.; Tajiri, K.; Koshiyama, Y.; Toyoda, H.; Ogawa, C.; Hatanaka, T.; Kakizaki, S.; Kawata, K.; Ohama, H.; Kosaka, H.; Kaibori, M.; Naganuma, A.; Matono, T.; Aoki, T.; Kudo, M.; Kuroda, H.; Yata, Y.
Source
In: Alimentary Pharmacology and Therapeutics . (Alimentary Pharmacology and Therapeutics, July 2024, 60(2):233-245)
Subject
Language
English
ISSN
13652036
02692813
02692813